Robert Thomas Freeman Alignment Healthcare, Inc. (ALHC) insider trading activity

Robert Thomas Freeman is Chief Financial Officer of Alignment Healthcare, Inc.. Currently has a direct ownership of 1.46 Million shares of ALHC, which is worth approximately $25.6 Million. The most recent transaction as insider was on Mar 27, 2025, when has been sold 6,744 shares (Common Stock) at a price of $17.89 per share, resulting in proceeds of $120,650. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.46M

69.22% 3M change

69.22% 12M change

Total Value Held $25.6 Million

Robert Thomas Freeman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 27 2025	SELL Open market or private sale	$120,650 $17.89 p/Share	6,744 Reduced 0.46%	1,464,419 Common Stock
Mar 19 2025	SELL Open market or private sale	$188,970 $16.53 p/Share	11,432 Reduced 0.77%	1,471,163 Common Stock
Mar 18 2025	SELL Open market or private sale	$233,335 $16.89 p/Share	13,815 Reduced 0.92%	1,482,595 Common Stock
Mar 13 2025	BUY Grant, award, or other acquisition	-	93,548 Added 5.88%	1,496,410 Common Stock
Mar 12 2025	SELL Open market or private sale	$228,901 $15.58 p/Share	14,692 Reduced 1.04%	1,402,862 Common Stock
Mar 06 2025	SELL Open market or private sale	$3,390,121 $15.53 p/Share	218,295 Reduced 13.34%	1,417,554 Common Stock
Mar 04 2025	SELL Open market or private sale	$3,895,000 $15.58 p/Share	250,000 Reduced 13.26%	1,635,849 Common Stock
Mar 04 2025	BUY Grant, award, or other acquisition	-	1,020,442 Added 35.11%	1,885,849 Common Stock
Mar 28 2024	SELL Open market or private sale	$20,807 $4.84 p/Share	4,299 Reduced 0.49%	865,407 Common Stock
Mar 19 2024	SELL Open market or private sale	$144,036 $5.05 p/Share	28,522 Reduced 3.18%	869,706 Common Stock
Mar 15 2024	SELL Open market or private sale	$57,985 $4.89 p/Share	11,858 Reduced 1.3%	898,228 Common Stock
Mar 13 2024	BUY Grant, award, or other acquisition	-	200,710 Added 18.07%	910,086 Common Stock
Mar 31 2023	SELL Open market or private sale	$20,595 $6.26 p/Share	3,290 Reduced 0.46%	709,376 Common Stock
Mar 29 2023	SELL Open market or private sale	$32,456 $6.11 p/Share	5,312 Reduced 0.74%	712,666 Common Stock
Mar 14 2023	SELL Open market or private sale	$85,265 $6.33 p/Share	13,470 Reduced 1.84%	717,978 Common Stock
Sep 12 2022	BUY Grant, award, or other acquisition	-	319,179 Added 30.38%	731,448 Common Stock
Apr 01 2022	SELL Open market or private sale	$37,595 $11.42 p/Share	3,292 Reduced 0.79%	412,269 Common Stock
Mar 31 2022	SELL Open market or private sale	$55,274 $11.18 p/Share	4,944 Reduced 1.18%	415,561 Common Stock
Mar 08 2022	BUY Grant, award, or other acquisition	-	136,589 Added 24.52%	420,505 Common Stock
Mar 25 2021	BUY Grant, award, or other acquisition	-	15,142 Added 5.97%	238,489 Common Stock
Mar 25 2021	BUY Grant, award, or other acquisition	-	57,090 Added 20.36%	223,347 Common Stock, par valu...

RTF

Robert Thomas Freeman

Chief Financial Officer

Orange, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALHC shares.

Notify only if

Value

Insider Trading

Get notified when an Alignment Healthcare, Inc. insider buys or sells ALHC shares.

Notify only if

Operation

Value

Type

News

Receive news related to Alignment Healthcare, Inc.

Track Activities on ALHC

Account